Trials / Completed
CompletedNCT00522782
Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
Phase IV Study of the Effect of Nebulized Budesonide on Exhaled Nitric Oxide in Children, Four to Six Years of Age, With Asthma
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- AAADRS Clinical Research Center · Academic / Other
- Sex
- All
- Age
- 4 Years – 6 Years
- Healthy volunteers
- Not accepted
Summary
To study the improvement in airway inflammation in children with asthma non-invasively with exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg daily.
Detailed description
Comparisons will be made before and after 2 week therapy of nebulized budesonide in children not on prior anti-inflammatory medications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nebulized Budesonide | Pulmicort Respules 0.5mg/2cc |
| DEVICE | Nitric Oxide Analyzer | Niox NO analyzer |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2008-12-01
- Completion
- 2009-01-01
- First posted
- 2007-08-30
- Last updated
- 2009-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00522782. Inclusion in this directory is not an endorsement.